Shahid Zikria

Mr. Shahid Zikria

Information Technology University, Lahore, Punjab, Pakistan
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
GAgulnaz ahmed
gulnaz ahmed
Meng Joo ErMeng Joo Er
Meng Joo Er
MFMian Muhammad Sadiq Fareed
Mian Muhammad Sadiq Fareed
Shahid ZikriaShahid Zikria
Shahid Zikria
MFMian Muhammad Sadiq Fareed
Mian Muhammad Sadiq Fareed
MAMUAHMMAD ASLAM
MUAHMMAD ASLAM
Alzheimer’s Disease (AD) is a neurological brain disorder that causes dementia and neurological dysfunction, affecting memory, behavior, and cognition. Deep Learning (DL), a kind of Artificial Intelligence (AI), has paved the way for new AD detection and automation methods. The DL model’s prediction accuracy depends on the dataset’s size. The DL models lose their accuracy when the dataset has an imbalanced class problem. This study aims to use the deep Convolutional Neural Network (CNN) to develop a reliable and efficient method for identifying Alzheimer’s disease using MRI. In this study, we offer a new CNN architecture for diagnosing Alzheimer’s disease with a modest number of parameters, making it perfect for training a smaller dataset. This proposed model correctly separates the early stages of Alzheimer’s disease and displays class activation patterns on the brain as a heat map. The proposed Detection of Alzheimer’s Disease Network (DAD-Net) is developed from scratch to correctly classify the phases of Alzheimer’s disease while reducing parameters and computation costs. The Kaggle MRI image dataset has a severe problem with class imbalance. Therefore, we used a synthetic oversampling technique to distribute the image throughout the classes and avoid the problem. Precision, recall, F1-score, Area Under the Curve (AUC), and loss are all used to compare the proposed DAD-Net against DEMENET and CNN Model. For accuracy, AUC, F1-score, precision, and recall, the DAD-Net achieved the following values for evaluation metrics: 99.22%, 99.91%, 99.19%, 99.30%, and 99.14%, respectively. The presented DAD-Net outperforms other state-of-the-art models in all evaluation metrics, according to the simulation results.

5 September 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
MFMian Muhammad Sadiq Fareed
Mian Muhammad Sadiq Fareed
MFMian Muhammad Sadiq Fareed
Mian Muhammad Sadiq Fareed
GAgulnaz ahmed
gulnaz ahmed
FDFarhan Dawood
Farhan Dawood
Shahid ZikriaShahid Zikria
Shahid Zikria
MAMUAHMMAD ASLAM
MUAHMMAD ASLAM
Accurate patient disease classification and detection through deep-learning (DL) models are increasingly contributing to the area of biomedical imaging. The most frequent gastrointestinal (GI) tract ailments are peptic ulcers and stomach cancer. Conventional endoscopy is a painful and hectic procedure for the patient while Wireless Capsule Endoscopy (WCE) is a useful technology for diagnosing GI problems and doing painless gut imaging. However, there is still a challenge to investigate thousands of images captured during the WCE procedure accurately and efficiently because existing deep models are not scored with significant accuracy on WCE image analysis. So, to prevent emergency conditions among patients, we need an efficient and accurate DL model for real-time analysis. In this study, we propose a reliable and efficient approach for classifying GI tract abnormalities using WCE images by applying a deep Convolutional Neural Network (CNN). For this purpose, we propose a custom CNN architecture named GI Disease-Detection Network (GIDD-Net) that is designed from scratch with relatively few parameters to detect GI tract disorders more accurately and efficiently at a low computational cost. Moreover, our model successfully distinguishes GI disorders by visualizing class activation patterns in the stomach bowls as a heat map. The Kvasir-Capsule image dataset has a significant class imbalance problem, we exploited a synthetic oversampling technique BORDERLINE SMOTE (BL-SMOTE) to evenly distribute the image among the classes to prevent the problem of class imbalance. The proposed model is evaluated against various metrics and achieved the following values for evaluation metrics: 98.9%, 99.8%, 98.9%, 98.9%, 98.8%, and 0.0474 for accuracy, AUC, F1-score, precision, recall, and loss, respectively. From the simulation results, it is noted that the proposed model outperforms other state-of-the-art models in all the evaluation metrics.

28 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MFMian Muhammad Sadiq Fareed
Mian Muhammad Sadiq Fareed
GAGulnaz Ahmed
Gulnaz Ahmed
Shahid ZikriaShahid Zikria
Shahid Zikria
Saad Ahmed JamalSaad Ahmed Jamal
Saad Ahmed Jamal
Alzheimer’s is a degenerative brain condition brought on by intricate brain changes after cell injury. The prevalence of Alzheimer’s disease is highest in those over 65. Presently, AD is detected by manual examination of a patient’s Magnetic Resonance Imaging (MRI) scan and neuropsychological assessments. Due to its subpar accuracy and performance, solutions based on artificial intelligence (AI) have not been made more widely available. This paper proposes a deep Convolutional Neural Network (CNN) with the pre-trained MobileNet-V2 architecture as the model’s base for feature extraction and reducing the parameter size and training time. The proposed model accurately classifies various early stages of AD. The proposed approach visualizes the class activation maps in the form of a heat map on brain MRI scans via the Grad-CAM algorithm that lifts the black-box nature of the deep model. To handle the imbalance problem of the AD data set acquired from Kaggle, the oversampling algorithm SMOTE interpolates new images to even the class samples. The proposed multi-class classification deep model is named Bio-AD and evaluated using different quality metrics. The Bio-AD model has the following values for evaluation metrics: 97.92%, 99.87%, 97.87%, 98%, 98%, and 0.0646 for accuracy, Area Under the Curve (AUC), F1-score, Precision, Recall, and loss respectively. The proposed Bio-AD model is compared with DenseNet-169, VGG-19, and InceptionResNet-V2 using different quality metrics and outperformed in comparison with all other models using the AD data set.